Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Sunburn? 27 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Sunburn have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.1% of all adverse event reports for CABOZANTINIB S-MALATE.

27
Reports of Sunburn with CABOZANTINIB S-MALATE
0.1%
of all CABOZANTINIB S-MALATE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Sunburn From CABOZANTINIB S-MALATE?

Of the 27 reports, 1 (3.7%) resulted in death, 1 (3.7%) required hospitalization.

Is Sunburn Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOZANTINIB S-MALATE. However, 27 reports have been filed with the FAERS database.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Sunburn?

ADAPALENE (408) PIRFENIDONE (350) AVOBENZONE\OCTISALATE\OCTOCRYLENE (304) DUPILUMAB (293) VEMURAFENIB (292) AVOBENZONE\HOMOSALATE\OCTISALATE\OCTOCRYLENE\OXYBENZONE (209) SUMATRIPTAN (202) ADALIMUMAB (184) ETANERCEPT (102) SECUKINUMAB (93)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Sunburn Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Sunburn Reports All Drugs Causing Sunburn CABOZANTINIB S-MALATE Demographics